Description: Caplin Point Laboratories Limited develops, manufactures, markets, and exports generic pharmaceutical formulations and branded generic products in India and internationally. It provides tablets, capsules, vials, ophthalmic products, liquid orals, soft gel capsules, ointments, creams and gels, powder for injections, suppositories and ovules, dermo cosmetics, surgicals and disposables, pre-mix bag formulations, inhalers and sprays, IV infusion products, dry syrups, topicals, and other products, as well as liquid, lyophilized, and pre-filled injection syringes. The company also operates QueTenX, an e-commerce website. Caplin Point Laboratories Limited was founded in 1990 and is based in Chennai, India.
Home Page: www.caplinpoint.net
Ashvich Tower
Chennai,
600096
India
Phone:
91 44 2496 8000
Officers
| Name | Title |
|---|---|
| Dr. Sridhar Ganesan | MD & Whole Time Director |
| Mr. D. Muralidharan | Chief Financial Officer |
| Mr. S. Vinod Kumar | Company Sec. & Compliance Officer |
| Mr. Partheeban Vivek Siddarth | Chief Operating Officer |
| Mr. V. Natarajan | Head of Formulation & Devel. -Injectibles |
| Mr. M. Sathya Narayanan | Deputy Chief Financial Officer |
Exchange: BSE
Country: IN
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 16.8966 |
| Price-to-Book MRQ: | 3.4754 |
| Price-to-Sales TTM: | 3.8858 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 1696 |